Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies

A Roos, R Roozendaal, J Theeuwsen, S Riahi… - Vaccine, 2015 - Elsevier
A Roos, R Roozendaal, J Theeuwsen, S Riahi, J Vaneman, J Tolboom, L Dekking…
Vaccine, 2015Elsevier
Background Current seasonal influenza vaccines are believed to confer protection against a
narrow range of virus strains. However, their protective ability is commonly estimated based
on an in vitro correlate of protection that only considers a subset of anti-influenza antibodies
that are typically strain specific, ie, hemagglutination inhibiting antibodies. Here, we evaluate
the breadth of protection induced with a seasonal trivalent influenza vaccine (composition
H1N1 A/California/07/09, H3N2 A/Victoria/210/08, B/Brisbane/60/08) against influenza …
Background
Current seasonal influenza vaccines are believed to confer protection against a narrow range of virus strains. However, their protective ability is commonly estimated based on an in vitro correlate of protection that only considers a subset of anti-influenza antibodies that are typically strain specific, i.e., hemagglutination inhibiting antibodies. Here, we evaluate the breadth of protection induced with a seasonal trivalent influenza vaccine (composition H1N1 A/California/07/09, H3N2 A/Victoria/210/08, B/Brisbane/60/08) against influenza challenge in mice.
Methods
Balb/c mice were immunized once, twice, or three times with seasonal influenza vaccine to assess protection against heterosubtypic H5N1 influenza challenge, or homologous H1N1 influenza virus as a control. Passive transfer of immune serum was used to determine the contribution of humoral immunity to protection.
Results
Multiple immunizations with seasonal influenza vaccine induced up to 80% protection against heterosubtypic H5N1 influenza challenge in mice without eliciting detectable H5N1 neutralizing antibodies. Comparable levels of protection were reached by passive transfer of immune serum, and protection was correlated with the titer of vaccine-induced, H5 cross-reactive, non-neutralizing antibodies that are at least in part directed against conserved HA epitopes.
Conclusions
Here, we demonstrate that seasonal vaccine has the ability to induce broad serum-mediated protection, and that the mechanism of this protection is different from the vaccine-induced homologous protection.
Elsevier